Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

Wissam H. Faour; Ali Choaib; Elio Issa; Francesca El Choueiry; Khodor Shbaklo; Maryline Alhajj; Ramy Touma Sawaya; Zeina Harhous; Eman Alefishat; Moni Nader

doi:10.1007/s00011-021-01520-8

Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

Wissam H. Faour
, Ali Choaib
, Elio Issa
, Francesca El Choueiry
, Khodor Shbaklo
, Maryline Alhajj
, Ramy Touma Sawaya
, Zeina Harhous
, Eman Alefishat
, Moni Nader

College of Medicine and Health Sciences

Lebanese American University

Research output: Contribution to journal › Review article › peer-review

41 Scopus citations

Abstract

The COVID-19 pandemic created a worldwide debilitating health crisis with the entire humanity suffering from the deleterious effects associated with the high infectivity and mortality rates. While significant evidence is currently available online and targets various aspects of the disease, both inflammatory and noninflammatory kidney manifestations secondary to COVID-19 infection are still largely underrepresented. In this review, we summarized current knowledge about COVID-19-related kidney manifestations, their pathologic mechanisms as well as various pharmacotherapies used to treat patients with COVID-19. We also shed light on the effect of these medications on kidney functions that can further enhance renal damage secondary to the illness.

Original language	British English
Pages (from-to)	39-56
Number of pages	18
Journal	Inflammation Research
Volume	71
Issue number	1
DOIs	https://doi.org/10.1007/s00011-021-01520-8
State	Published - Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Angiotensin
COVID-19
Inflammation
Kidney
Renal pathology

Access to Document

10.1007/s00011-021-01520-8

OpenUrl availability

Full text

Cite this

@article{5fe6091b4415497484ef5e404af8d770,

title = "Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies",

abstract = "The COVID-19 pandemic created a worldwide debilitating health crisis with the entire humanity suffering from the deleterious effects associated with the high infectivity and mortality rates. While significant evidence is currently available online and targets various aspects of the disease, both inflammatory and noninflammatory kidney manifestations secondary to COVID-19 infection are still largely underrepresented. In this review, we summarized current knowledge about COVID-19-related kidney manifestations, their pathologic mechanisms as well as various pharmacotherapies used to treat patients with COVID-19. We also shed light on the effect of these medications on kidney functions that can further enhance renal damage secondary to the illness.",

keywords = "Angiotensin, COVID-19, Inflammation, Kidney, Renal pathology",

author = "Faour, \{Wissam H.\} and Ali Choaib and Elio Issa and Choueiry, \{Francesca El\} and Khodor Shbaklo and Maryline Alhajj and Sawaya, \{Ramy Touma\} and Zeina Harhous and Eman Alefishat and Moni Nader",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2022",

month = jan,

doi = "10.1007/s00011-021-01520-8",

language = "British English",

volume = "71",

pages = "39--56",

journal = "Inflammation Research",

issn = "1023-3830",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

AU - Faour, Wissam H.

AU - Choaib, Ali

AU - Issa, Elio

AU - Choueiry, Francesca El

AU - Shbaklo, Khodor

AU - Alhajj, Maryline

AU - Sawaya, Ramy Touma

AU - Harhous, Zeina

AU - Alefishat, Eman

AU - Nader, Moni

PY - 2022/1

Y1 - 2022/1

N2 - The COVID-19 pandemic created a worldwide debilitating health crisis with the entire humanity suffering from the deleterious effects associated with the high infectivity and mortality rates. While significant evidence is currently available online and targets various aspects of the disease, both inflammatory and noninflammatory kidney manifestations secondary to COVID-19 infection are still largely underrepresented. In this review, we summarized current knowledge about COVID-19-related kidney manifestations, their pathologic mechanisms as well as various pharmacotherapies used to treat patients with COVID-19. We also shed light on the effect of these medications on kidney functions that can further enhance renal damage secondary to the illness.

AB - The COVID-19 pandemic created a worldwide debilitating health crisis with the entire humanity suffering from the deleterious effects associated with the high infectivity and mortality rates. While significant evidence is currently available online and targets various aspects of the disease, both inflammatory and noninflammatory kidney manifestations secondary to COVID-19 infection are still largely underrepresented. In this review, we summarized current knowledge about COVID-19-related kidney manifestations, their pathologic mechanisms as well as various pharmacotherapies used to treat patients with COVID-19. We also shed light on the effect of these medications on kidney functions that can further enhance renal damage secondary to the illness.

KW - Angiotensin

KW - COVID-19

KW - Inflammation

KW - Kidney

KW - Renal pathology

UR - https://www.scopus.com/pages/publications/85119500026

U2 - 10.1007/s00011-021-01520-8

DO - 10.1007/s00011-021-01520-8

M3 - Review article

C2 - 34802072

AN - SCOPUS:85119500026

SN - 1023-3830

VL - 71

SP - 39

EP - 56

JO - Inflammation Research

JF - Inflammation Research

IS - 1

ER -

Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

Abstract

UN SDGs

Keywords

Access to Document

OpenUrl availability

Other files and links

Fingerprint

Cite this